Severity
Critical
FDA Drug recall · Reported February 11, 2026
CGMP Deviations: product found to contain lead.
Handelnine Global LLC recalled Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmeda… - a critical-severity action.
Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmeda… was recalled by Handelnine Global LLC in February 11, 2026. Reason: CGMP Deviations: product found to contain lead.. Check the official notice for the remedy. Verify recall #D-0332-2026 with the FDA Drug before acting.
The recall
Handelnine Global LLC issued this critical-severity FDA Drug recall-CGMP Deviations: product found to contain lead..
Sourced from official FDA Drug enforcement records. Verify recall #D-0332-2026 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0332-2026) was formally reported on February 11, 2026, with the manufacturer initiating the action on December 22, 2025. It is classified under Critical severity (Class I), with a current status of Ongoing. Handelnine Global LLC is listed as the recalling firm, operating out of South Plainfield, NJ. Federal records list the affected scope as 4 bottles /30 capsules each.
The documented reason for this recall is: CGMP Deviations: product found to contain lead. Distribution data in the federal record shows the product reached: Product was distributed to one customer in NY.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 3,731 children & baby products recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified high severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Critical
Affected scope
4 bottles /30 capsules each
Related Recalls
6
0 from same agency
Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313
CGMP Deviations: product found to contain lead.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Critical (Class I) |
| Status | Ongoing |
| Recall number | D-0332-2026 |
| Date reported | February 11, 2026 |
| Date initiated | December 22, 2025 |
| Recalling firm | Handelnine Global LLC |
| Firm location | South Plainfield, NJ |
| Affected scope | 4 bottles /30 capsules each |
| Distribution | Product was distributed to one customer in NY. |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
Xishentang Dongguan Trading Co, Ltd., dba Pretty-Life, of China · 2026-07-02
Diamond Wipes International, Inc. of Chino, California · 2026-07-02
· 2026-07-02
· 2026-07-02
Sanven Technology Ltd., dba Vevor, of Rancho Cucamonga, California · 2026-07-02
Compare this recall with AMASKY Nursing Pillows Recalled Due to Risk of Serious Inju… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported February 11, 2026. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.